Cleared Traditional

K843269 - SYSTEMATE LDH

K843269 is the FDA 510(k) clearance for SYSTEMATE LDH by Em Diagnostic Systems, Inc.. It is a Class 2 Chemistry device (product code CFJ) cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K843269 · Em Diagnostic Systems, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
24d
Days
Class 2
Risk

K843269 is an FDA 510(k) clearance for the SYSTEMATE LDH, 67210. Classified as Nad Reduction/nadh Oxidation, Lactate Dehydrogenase (product code CFJ), Class II - Special Controls.

Submitted by Em Diagnostic Systems, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 13, 1984 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Em Diagnostic Systems, Inc. devices

Submission Details

510(k) Number K843269 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 1984
Decision Date September 13, 1984
Days to Decision 24 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 88d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

All 83
Devices cleared under the same product code (CFJ) and FDA review panel - the closest regulatory comparables to K843269.
LDH (OPTIMIZED) REAGENT
K860029 · Sigma Chemical Co. · Feb 1986
ULTRAZYME PLUS & SYSTEMATE LDH
K854585 · Em Diagnostic Systems, Inc. · Dec 1985
AMRESCO SUBST CONCEN, PRO #2432,BUF,NAD,2455,TRI
K852948 · Amresco, Inc. · Aug 1985
LACTATE DEHYDROGENASE ASSAY KIT
K842507 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
LACTATE DENYDRO GENASE ASSAY KIT
K842244 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SIGMS PROCED. 228 UV LACTATE DEHYDRO
K841917 · Sigma Diagnostics, Inc. · Jun 1984